Mutations in the endoglin gene (ENG) are responsible for HHT type 1 (HHT1) (27), while mutations in activing receptor-like kinase (ACVRL1 alias ALK1) are responsible for HHT2 (2, 27). This evidence concerns the gene ACVRL1 and telangiectasia, hereditary hemorrhagic, type 1.